Cargando…
Ivacaftor Inhibits Glioblastoma Stem Cell Maintenance and Tumor Progression
Glioblastoma (GBM) is the most common and malignant primary brain tumor. Glioblastoma stem cells (GSCs) not only initiate and sustain uncontrolled cell proliferation but also resistant to conventional clinical therapies including temozolomide (TMZ) dependent chemotherapy and radiotherapy, implying t...
Autores principales: | Liu, Kun, Pu, Jun, Nie, Zhi, Shi, Yulin, Jiang, Liping, Wu, Qisheng, Chen, Yongbin, Yang, Cuiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147559/ https://www.ncbi.nlm.nih.gov/pubmed/34046412 http://dx.doi.org/10.3389/fcell.2021.678209 |
Ejemplares similares
-
RETSAT Mutation Selected for Hypoxia Adaptation Inhibits Tumor Growth
por: Jiang, Xiulin, et al.
Publicado: (2021) -
Research Progress of circRNAs in Glioblastoma
por: Guo, Xu, et al.
Publicado: (2021) -
Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma
por: Liu, Kun, et al.
Publicado: (2022) -
CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018) -
Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis
por: Wang, Ganping, et al.
Publicado: (2021)